{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:58:18Z","timestamp":1783479498591,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ijantimicag.2014.11.017","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T21:26:39Z","timestamp":1422912399000},"page":"406-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis"],"prefix":"10.1016","volume":"45","author":[{"given":"Ximena","family":"Gonzalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Casali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Broda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Pardieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Drobniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2014.11.017_bib0195","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1093\/infdis\/jir858","article-title":"Drug-resistant tuberculosis\u2014current dilemmas, unanswered questions, challenges, and priority needs","volume":"205","author":"Zumla","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0200","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for multidrug-resistant pulmonary tuberculosis","volume":"366","author":"Gler","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0205","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2217\/fmb.13.85","article-title":"TMC207 becomes bedaquiline, a new anti-TB drug","volume":"8","author":"Palomino","year":"2013","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/jac\/47.5.505","article-title":"Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy","volume":"47","author":"Amaral","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijantimicag.2005.05.005","article-title":"Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis","volume":"26","author":"Bhusal","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0220","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1128\/AAC.01658-08","article-title":"Tuberculosis and trimethoprim\u2013sulfamethoxazole","volume":"53","author":"Forgacs","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0225","first-page":"385","article-title":"Tetracyclines and chloramphenicol","volume":"vol. 1","author":"Salvatore","year":"2010"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0230","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10096-004-1268-4","article-title":"Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy","volume":"24","author":"Balabanova","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0235","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1128\/AAC.48.7.2415-2423.2004","article-title":"Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis","volume":"48","author":"Li","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0240","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/jac\/dkl510","article-title":"Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG","volume":"59","author":"Ram\u00f3n-Garc\u00eda","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrmicro3155","article-title":"Ribosome-targeting antibiotics and mechanisms of bacterial resistance","volume":"12","author":"Wilson","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0250","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.eimc.2009.10.002","article-title":"Tetracyclines, sulfonamides, and metronidazole [in Spanish]","volume":"28","author":"Vicente","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0255","first-page":"347","article-title":"Pharmacokinetics and bioequivalence study of doxycycline capsules in healthy male subjects","volume":"57","author":"Gschwend","year":"2007","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0260","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/jac\/4.6.509","article-title":"The absorption and sputum penetration of doxycycline","volume":"4","author":"MacArthur","year":"1978","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.contraception.2008.09.006","article-title":"Doxycycline serum levels at the time of dilation and evacuation with two dosing regimens","volume":"79","author":"Reeves","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0270","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1378\/chest.78.2.304","article-title":"Tissue levels of doxycycline in the human lung and pleura","volume":"78","author":"Thadepalli","year":"1980","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0275","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/09031936.00073611","article-title":"WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update","volume":"38","author":"Falzon","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0280","series-title":"Guidelines for surveillance of drug resistance in tuberculosis","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0285","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JCM.44.3.811-818.2006","article-title":"Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis","volume":"44","author":"Kr\u00fc\u00fcner","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0290","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/JCM.02501-08","article-title":"Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation","volume":"47","author":"Springer","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose\u2013effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0305","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2878","article-title":"Evolution and transmission of drug-resistant tuberculosis in a Russian population","volume":"46","author":"Casali","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0310","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1365-2958.1993.tb01253.x","article-title":"Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot","volume":"9","author":"Finken","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0315","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. Document M100-S23","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0320","first-page":"375","article-title":"Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media","volume":"65","author":"Kamala","year":"1997","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0325","first-page":"410","article-title":"The antitubercular activity of oxytetracycline [in Ukrainian]","volume":"31","author":"Ginzburg","year":"1969","journal-title":"Mikrobiol Zh"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0330","first-page":"367","article-title":"Antituberculous activity of tetracycline and related compounds","volume":"72","author":"Hobby","year":"1955","journal-title":"Am Rev Tuberc"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0335","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1164\/rccm.201110-1769OC","article-title":"Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases","volume":"185","author":"Walker","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0340","first-page":"1202","article-title":"Bacteriostatic action of tetracycline, alone or combined with antituberculosis antibiotics, on Mycobacterium tuberculosis [in French]","volume":"150","author":"Cayre","year":"1956","journal-title":"C R Seances Soc Biol Fil"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0345","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/bj20020615","article-title":"Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis","volume":"367","author":"Choudhuri","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0350","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/AAC.45.3.800-804.2001","article-title":"Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis","volume":"45","author":"Silva","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0355","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/JB.180.22.5836-5843.1998","article-title":"Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis","volume":"180","author":"A\u00ednsa","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0360","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1574-6976.2005.00002.x","article-title":"Role of mycobacterial efflux transporters in drug resistance: an unresolved question","volume":"30","author":"De Rossi","year":"2006","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0365","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/mdr.2009.0054","article-title":"Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs","volume":"16","author":"Gupta","year":"2010","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0370","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.diagmicrobio.2013.02.033","article-title":"Expression analysis of efflux pump genes among drug-susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates and reference strains","volume":"76","author":"Calgin","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0375","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12223-011-0080-7","article-title":"The role of ABC efflux pump, Rv1456c-Rv1457c-Rv1458c, from Mycobacterium tuberculosis clinical isolates in China","volume":"56","author":"Hao","year":"2011","journal-title":"Folia Microbiol (Praha)"},{"key":"10.1016\/j.ijantimicag.2014.11.017_bib0380","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1472-9792(08)70021-0","article-title":"Pyrazinamide","volume":"88","year":"2008","journal-title":"Tuberculosis (Edinb)"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791500045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791500045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T15:57:24Z","timestamp":1598716644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791500045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S092485791500045X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.11.017","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}